دورية أكاديمية

Changes in Muscle Metabolism are Associated with Phenotypic Variability in Golden Retriever Muscular Dystrophy

التفاصيل البيبلوغرافية
العنوان: Changes in Muscle Metabolism are Associated with Phenotypic Variability in Golden Retriever Muscular Dystrophy
المؤلفون: Nghiem, Peter P, Bello, Luca, Stoughton, William B, López, Sara Mata, Vidal, Alexander H, Hernandez, Briana V, Hulbert, Katherine N, Gourley, Taylor R, Bettis, Amanda K, Balog-Alvarez, Cynthia J, Heath-Barnett, Heather, Kornegay, Joe N
المساهمون: Nghiem, Peter P, Bello, Luca, Stoughton, William B, López, Sara Mata, Vidal, Alexander H, Hernandez, Briana V, Hulbert, Katherine N, Gourley, Taylor R, Bettis, Amanda K, Balog-Alvarez, Cynthia J, Heath-Barnett, Heather, Kornegay, Joe N
سنة النشر: 2017
المجموعة: Padua Research Archive (IRIS - Università degli Studi di Padova)
مصطلحات موضوعية: AMPK, Duchenne, dystrophin, golden retriever muscular dystrophy, metabolism, muscle, phenotype, AMP-Activated Protein Kinase, Adolescent, Animal, Child, Dog, Human, Male, Mitochondria, Skeletal, Muscular Dystrophy, Mutation
الوصف: Duchenne muscular dystrophy (DMD) is an X-chromosome-linked disorder and the most common monogenic disease in people. Affected boys are diagnosed at a young age, become non-ambulatory by their early teens, and succumb to cardiorespiratory failure by their thirties. Despite being a monogenic condition resulting from mutations in the DMD gene, affected boys have noteworthy phenotypic variability. Efforts have identified genetic modifiers that could modify disease progression and be pharmacologic targets. Dogs affected with golden retriever muscular dystrophy (GRMD) have absent dystrophin and demonstrate phenotypic variability at the functional, histopathological, and molecular level. Our laboratory is particularly interested in muscle metabolism changes in dystrophin-deficient muscle. We identified several metabolic alterations, including myofiber type switching from fast (type II) to slow (type I), reduced glycolytic enzyme expression, reduced and morphologically abnormal mitochondria, and differential AMP-kinase phosphorylation (activation) between hypertrophied and wasted muscle. We hypothesize that muscle metabolism changes are, in part, responsible for phenotypic variability in GRMD. Pharmacological therapies aimed at modulating muscle metabolism can be tested in GRMD dogs for efficacy.
نوع الوثيقة: article in journal/newspaper
اللغة: English
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28955176; info:eu-repo/semantics/altIdentifier/wos/WOS:000412701100002; volume:90; issue:3; firstpage:351-360; journal:THE YALE JOURNAL OF BIOLOGY AND MEDICINE; http://hdl.handle.net/11577/3275180Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85030244859
الإتاحة: http://hdl.handle.net/11577/3275180Test
حقوق: info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.23ED4A9
قاعدة البيانات: BASE